ZAVZPRET Trademark

Trademark Overview

On Thursday, February 24, 2022, a trademark application was filed for ZAVZPRET with the United States Patent and Trademark Office. The USPTO has given the ZAVZPRET trademark a serial number of 97283354. The federal status of this trademark filing is REGISTERED as of Tuesday, April 30, 2024. This trademark is owned by Biohaven Pharmaceutical Ireland DAC. The ZAVZPRET trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of headache and facial pain, namely, headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia
zavzpret

General Information

Serial Number97283354
Word MarkZAVZPRET
Filing DateThursday, February 24, 2022
Status700 - REGISTERED
Status DateTuesday, April 30, 2024
Registration Number7375200
Registration DateTuesday, April 30, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of headache and facial pain, namely, headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 2, 2022
Primary Code005
First Use Anywhere DateMonday, July 31, 2023
First Use In Commerce DateMonday, July 31, 2023

Trademark Owner History

Party NamePFIZER IRELAND PHARMACEUTICALS
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressRINGASKIDDY
IE
Party NameBiohaven Pharmaceutical Ireland DAC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDublin 4D04TR29
IE
Party NameBiohaven Pharmaceutical Ireland DAC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDublin 4D04TR29
IE
Party NameBiohaven Pharmaceutical Ireland DAC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRingaskiddy CountyCor
IE

Trademark Events

Event DateEvent Description
Wednesday, March 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 28, 2022NEW APPLICATION ENTERED
Thursday, October 27, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 27, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 27, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 27, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 27, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 7, 2022ASSIGNED TO EXAMINER
Thursday, December 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 3, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Wednesday, May 3, 2023WITHDRAWAL OF ATTORNEY GRANTED
Thursday, May 4, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 4, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 4, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 13, 2023SOU EXTENSION 1 GRANTED
Wednesday, September 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 13, 2023SOU EXTENSION 1 FILED
Monday, March 4, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 4, 2024SOU EXTENSION 2 FILED
Monday, March 4, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 4, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 7, 2024USE AMENDMENT FILED
Wednesday, March 27, 2024SOU EXTENSION 2 GRANTED
Wednesday, March 27, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 4, 2024SOU TEAS EXTENSION RECEIVED
Thursday, March 7, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, March 27, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 28, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 29, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 30, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, September 5, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, April 30, 2024REGISTERED-PRINCIPAL REGISTER

Related Keywords

zavzpret headache pharmaceutical preparations pain treatment cluster trigeminal daily neuralgia namely